Home › Prostate Cancer › New York
Prostate Cancer clinical trials in New York
123 studies for Prostate Cancer are looking for participants at sites in New York.
Cities in New York
- New York City101 studies
- Queens27 studies
- Staten Island17 studies
- Greenburgh17 studies
- New Rochelle16 studies
- The Bronx12 studies
- Rochester10 studies
- Buffalo10 studies
- Syracuse9 studies
- Brooklyn6 studies
- Albany5 studies
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Northwell Health Imbert Cancer Center, Bay Shore
- Northwell Health Physicians Partners Radiation Medicine at Queens, Forest Hills
- Northwell Health/Center for Advanced Medicine, Lake Success
- and 14 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 13, 2026 · NCT04423211Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Yale New Haven Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT04221542Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Integrated Medical Professionals, New York
Recruiting
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT06511141WATER IV PCa (AS Sub-study)
- Albany Medical College, Albany
- Integrated Medical Professionals, PLLC, New York
- University of Rochester Medical Center, Rochester
Recruiting
Ages 45 and older · Men · Updated Nov 6, 2026 · NCT07650448ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 6, 2026 · NCT06141993A Study of Changes to Prostate Procedures
- Memorial Sloan Kettering Suffolk-Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 5, 2026 · NCT06986083A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06465069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07114601Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Hospital, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06632977A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Langone Health at NYC University, NYU School of Medicine, New York
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07746713A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
- Montefiore Medical Center, The Bronx
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06095089Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- and 4 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07200830MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06954337Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Guthrie Cortland Memorial Hospital, Cortland
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06931340Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Memorial Sloan Kettering Cancer Center, Long Island City
- Associated Medical Professionals, Syracuse
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT06800313A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
- Columbia University Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07319871A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Associated Medical Professionals, Syracuse
RecruitingPhase 2
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07832292A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Columbia University Medical Center, New York
RecruitingPhase 1
Ages 18 and older · Men · Updated Nov 3, 2026 · NCT07082920A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
- Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities), Commack
- Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · Men · Updated Oct 30, 2026 · NCT05751434A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Icahn School of Medicine at Mount Sinai ( Site 0009), New York
- Great Lakes Cancer Care ( Site 0047), Williamsville
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 30, 2026 · NCT06925737Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Northwell Health R.J. Zuckerberg Cancer Hospital, Lake Success
- NYU Langone Health Long Island, Mineola
- NYU Langone Health, New York
- and 3 more
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Oct 29, 2026 · NCT05519449A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- James J. Peters VA Medical Center, Bronx, NY, The Bronx
RecruitingPhase 2
Ages 18 and older · Men · Updated Oct 26, 2026 · NCT05593497Precision-Based Genomics in Prostate Cancer
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai Hospital, New York
- Weill Cornell Medicine, New York
RecruitingObservational study
Ages 18 to 120 · Men · Updated Oct 26, 2026 · NCT04706663A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute IDS, Buffalo
- Memorial Sloan Kettering Hospital, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06172478Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Northwell Health Imbert Cancer Center, Bay Shore
- New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn
- Sands Cancer Center, Canandaigua
- and 25 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, New York
RecruitingPhase 1/2
Ages 18 to 130 · Men · Updated Oct 22, 2026 · NCT07181161A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 107, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT05914116A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- START New York Long Island, LLC, New Hyde Park
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- and 1 more
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07103018A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Associated Medical Professionals - Urology ( Site 0081), Syracuse
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06136650Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- New York Cancer & Blood Specialists, New York
- University of Rochester - Wilmot Cancer Institute, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06582017A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Hematology Oncology Association of Central New York, East Syracuse
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07213674AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, New Hyde Park
- Research Site, New York
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 19, 2026 · NCT07611110A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, New York
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 16, 2026 · NCT06879041Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Shirley
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 15, 2026 · NCT07711002Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Bassett Medical Center, Cooperstown
- Weill Cornell Medicine NY-Presb, New York
- University of Rochester Medical Ctr, Rochester
- and 2 more
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Oct 15, 2026 · NCT06855277Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, New York
RecruitingPhase 1/2
Ages 18 to 99 · Men · Updated Oct 14, 2026 · NCT07590934A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, New York
- Research Site, Syracuse
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT06952803This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- MSK Commack, Commack
- MSKCC-Westchester (500 Westchester Ave.), Harrison
- Integrated Medical Professionals, Lake Success
- and 10 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT07028853From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.